chr9-36246500-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBP6_Very_Strong

The NM_001128227.3(GNE):​c.258-18A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000652 in 1,577,904 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00037 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00068 ( 0 hom. )

Consequence

GNE
NM_001128227.3 intron

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.496

Publications

0 publications found
Variant links:
Genes affected
GNE (HGNC:23657): (glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase) The protein encoded by this gene is a bifunctional enzyme that initiates and regulates the biosynthesis of N-acetylneuraminic acid (NeuAc), a precursor of sialic acids. It is a rate-limiting enzyme in the sialic acid biosynthetic pathway. Sialic acid modification of cell surface molecules is crucial for their function in many biologic processes, including cell adhesion and signal transduction. Differential sialylation of cell surface molecules is also implicated in the tumorigenicity and metastatic behavior of malignant cells. Mutations in this gene are associated with sialuria, autosomal recessive inclusion body myopathy, and Nonaka myopathy. Alternative splicing of this gene results in transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]
CLTA (HGNC:2090): (clathrin light chain A) Clathrin is a large, soluble protein composed of heavy and light chains. It functions as the main structural component of the lattice-type cytoplasmic face of coated pits and vesicles which entrap specific macromolecules during receptor-mediated endocytosis. This gene encodes one of two clathrin light chain proteins which are believed to function as regulatory elements. Alternative splicing results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 8 and 12. [provided by RefSeq, May 2010]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BP6
Variant 9-36246500-T-C is Benign according to our data. Variant chr9-36246500-T-C is described in CliVar as Likely_benign. Clinvar id is 257525.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-36246500-T-C is described in CliVar as Likely_benign. Clinvar id is 257525.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-36246500-T-C is described in CliVar as Likely_benign. Clinvar id is 257525.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-36246500-T-C is described in CliVar as Likely_benign. Clinvar id is 257525.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-36246500-T-C is described in CliVar as Likely_benign. Clinvar id is 257525.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-36246500-T-C is described in CliVar as Likely_benign. Clinvar id is 257525.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-36246500-T-C is described in CliVar as Likely_benign. Clinvar id is 257525.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-36246500-T-C is described in CliVar as Likely_benign. Clinvar id is 257525.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-36246500-T-C is described in CliVar as Likely_benign. Clinvar id is 257525.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-36246500-T-C is described in CliVar as Likely_benign. Clinvar id is 257525.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-36246500-T-C is described in CliVar as Likely_benign. Clinvar id is 257525.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-36246500-T-C is described in CliVar as Likely_benign. Clinvar id is 257525.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-36246500-T-C is described in CliVar as Likely_benign. Clinvar id is 257525.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GNENM_001128227.3 linkc.258-18A>G intron_variant Intron 2 of 11 ENST00000396594.8 NP_001121699.1 Q9Y223-2
GNENM_005476.7 linkc.165-18A>G intron_variant Intron 2 of 11 ENST00000642385.2 NP_005467.1 Q9Y223-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GNEENST00000396594.8 linkc.258-18A>G intron_variant Intron 2 of 11 1 NM_001128227.3 ENSP00000379839.3 Q9Y223-2
GNEENST00000642385.2 linkc.165-18A>G intron_variant Intron 2 of 11 NM_005476.7 ENSP00000494141.2 Q9Y223-1

Frequencies

GnomAD3 genomes
AF:
0.000369
AC:
56
AN:
151764
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000484
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000657
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000380
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000706
Gnomad OTH
AF:
0.000480
GnomAD2 exomes
AF:
0.000265
AC:
65
AN:
244986
AF XY:
0.000247
show subpopulations
Gnomad AFR exome
AF:
0.0000663
Gnomad AMR exome
AF:
0.0000290
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000377
Gnomad NFE exome
AF:
0.000502
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000682
AC:
973
AN:
1426140
Hom.:
0
Cov.:
26
AF XY:
0.000646
AC XY:
460
AN XY:
711878
show subpopulations
African (AFR)
AF:
0.0000609
AC:
2
AN:
32832
American (AMR)
AF:
0.0000896
AC:
4
AN:
44646
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25882
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39540
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85460
European-Finnish (FIN)
AF:
0.000327
AC:
17
AN:
51962
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4830
European-Non Finnish (NFE)
AF:
0.000847
AC:
916
AN:
1081916
Other (OTH)
AF:
0.000576
AC:
34
AN:
59072
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
47
94
141
188
235
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000369
AC:
56
AN:
151764
Hom.:
0
Cov.:
32
AF XY:
0.000351
AC XY:
26
AN XY:
74074
show subpopulations
African (AFR)
AF:
0.0000484
AC:
2
AN:
41284
American (AMR)
AF:
0.0000657
AC:
1
AN:
15212
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4814
European-Finnish (FIN)
AF:
0.000380
AC:
4
AN:
10540
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000706
AC:
48
AN:
67954
Other (OTH)
AF:
0.000480
AC:
1
AN:
2084
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000256
Hom.:
0
Bravo
AF:
0.000329

ClinVar

Significance: Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Mar 21, 2016
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 14, 2024
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sialuria;C1853926:GNE myopathy Benign:1
Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.75
CADD
Benign
7.3
DANN
Benign
0.62
PhyloP100
-0.50
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs374105190; hg19: chr9-36246497; API